ArticleCell reports. Medicine2023

Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.

Yunguang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.